Enhabit (EHAB) Stock Forecast, Price Target & Predictions
EHAB Stock Forecast
Enhabit (EHAB) stock forecast, based on 11 Wall Street analysts, predicts a 12-month average price target of $12.13, with a high of $14.00 and a low of $10.50. This represents a 17.54% increase from the last price of $10.32.
EHAB Stock Rating
Enhabit stock's rating consensus is Buy, based on 11 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 5 Buy (45.45%), 5 Hold (45.45%), 1 Sell (9.09%), and 0 Strong Sell (0.00%).
Buy
EHAB Price Target Upside V Benchmarks
| Type | Name | Upside |
|---|---|---|
| Stock | Enhabit | 17.54% |
| Sector | Healthcare Stocks | 15.45% |
| Industry | Medical Care Facilities Stocks | 23.46% |
Price Target Trends
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | 3 | 4 | 4 |
| Avg Price Target | $12.17 | $12.13 | $12.13 |
| Last Closing Price | $10.32 | $10.32 | $10.32 |
| Upside/Downside | 17.93% | 17.54% | 17.54% |
Ratings Trends
| Date | Strong Buy | Buy | Hold | Sell | Strong Sell | Total |
|---|---|---|---|---|---|---|
| Jan, 26 | - | 1 | 4 | - | - | 5 |
| Dec, 25 | - | 1 | 4 | - | - | 5 |
| Nov, 25 | - | 1 | 4 | - | - | 5 |
| Oct, 25 | - | 1 | 4 | - | - | 5 |
| Sep, 25 | - | 1 | 4 | - | - | 5 |
Analyst Price Target Forecasts
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Jan 22, 2026 | Michael Wiederhorn | Oppenheimer | $14.00 | $10.74 | 30.35% | 35.66% |
| Jan 08, 2026 | Wolfe Research | $12.00 | $9.51 | 26.18% | 16.28% | |
| Jan 07, 2026 | Truist Financial | $10.50 | $9.44 | 11.23% | 1.74% | |
| Dec 16, 2025 | Jefferies | $12.00 | $9.73 | 23.33% | 16.28% | |
| Dec 09, 2024 | Brian Tanquilut | Jefferies | $9.50 | $7.73 | 22.90% | -7.95% |
| May 14, 2024 | Whit Mayo | Leerink Partners | $8.50 | $8.64 | -1.62% | -17.64% |
| Dec 08, 2022 | UBS | $12.00 | $13.99 | -14.22% | 16.28% |
Analyst Rating Forecasts
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Jan 22, 2026 | Oppenheimer | Perform | Outperform | upgrade |
| Jan 13, 2026 | Cowen & Co. | Buy | upgrade | |
| Jan 13, 2026 | Deutsche Bank | Buy | upgrade | |
| Jan 08, 2026 | UBS | Neutral | Buy | upgrade |
| Dec 16, 2025 | Citigroup | Buy | Buy | hold |
| Mar 06, 2025 | Jefferies | Buy | Buy | hold |
| May 14, 2024 | Leerink Partners | Market Perform | upgrade | |
| May 09, 2024 | Jefferies | Hold | downgrade | |
| Mar 07, 2024 | UBS | Sell | Neutral | upgrade |
| Aug 11, 2023 | Credit Suisse | Neutral | Neutral | hold |
Financial Forecast
EPS Forecast
Annual
| Dec 22 | Dec 23 | Dec 24 | Dec 25 | Dec 26 | Dec 27 | |
|---|---|---|---|---|---|---|
| Reported | $1.25 | $-1.61 | $-3.11 | - | - | - |
| Avg Forecast | $1.42 | $0.18 | $0.22 | $0.29 | $0.36 | $0.27 |
| High Forecast | $1.45 | $0.20 | $0.24 | $0.40 | $0.51 | $0.27 |
| Low Forecast | $1.39 | $0.16 | $0.21 | $0.23 | $0.28 | $0.26 |
| Surprise % | -11.97% | -994.44% | -1513.64% | - | - | - |
Revenue Forecast
Annual
| Dec 22 | Dec 23 | Dec 24 | Dec 25 | Dec 26 | Dec 27 | |
|---|---|---|---|---|---|---|
| Reported | $1.08B | $1.05B | $1.03B | - | - | - |
| Avg Forecast | $1.08B | $1.05B | $1.04B | $1.07B | $1.12B | $1.19B |
| High Forecast | $1.09B | $1.07B | $1.06B | $1.09B | $1.12B | $1.22B |
| Low Forecast | $1.06B | $1.04B | $1.03B | $1.06B | $1.12B | $1.16B |
| Surprise % | 0.71% | 0.04% | -0.09% | - | - | - |
Net Income Forecast
Annual
| Dec 22 | Dec 23 | Dec 24 | Dec 25 | Dec 26 | Dec 27 | |
|---|---|---|---|---|---|---|
| Reported | $62.50M | $-80.50M | $-156.20M | - | - | - |
| Avg Forecast | $70.99M | $9.16M | $11.37M | $12.77M | $16.46M | $13.25M |
| High Forecast | $72.27M | $10.18M | $12.12M | $20.21M | $25.55M | $13.55M |
| Low Forecast | $69.60M | $8.15M | $10.61M | $11.62M | $13.89M | $12.95M |
| Surprise % | -11.96% | -978.42% | -1474.22% | - | - | - |